These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4533155

  • 1. Platelet function abnormalities in the myeloproliferative disorders.
    Adams T, Schutz L, Goldberg L.
    Scand J Haematol; 1974; 13(3):215-24. PubMed ID: 4533155
    [No Abstract] [Full Text] [Related]

  • 2. Haemostatic defects in polycythaemia vera.
    Stathakis NE, Papayannis AG, Arapakis G, Gardikas C.
    Blut; 1974 Aug; 29(2):77-86. PubMed ID: 4852216
    [No Abstract] [Full Text] [Related]

  • 3. Abnormalities of platelet function in patients with polycythemia vera.
    Berger S, Aledort LM, Gilbert HS, Hanson JP, Wasserman LR.
    Cancer Res; 1973 Nov; 33(11):2683-7. PubMed ID: 4748429
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T, Battista R, Dini E.
    Acta Haematol; 1973 Nov; 50(1):25-9. PubMed ID: 4200801
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased sensitivity of platelets to adrenaline in human myotonic dystrophy.
    Bousser MG, Conard J, Lecrubier C, Samama M.
    Lancet; 1975 Aug 16; 2(7929):307-9. PubMed ID: 50512
    [Abstract] [Full Text] [Related]

  • 9. Biosynthetic activities in normal and pathological platelet populations.
    Vainer H, Lukasiewicz H, Janneau C, Caen J.
    Acta Univ Carol Med Monogr; 1972 Aug 16; 53():105-12. PubMed ID: 4208681
    [No Abstract] [Full Text] [Related]

  • 10. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I, Kahn SB, Ross EM, Petkov G.
    Cancer; 1972 Dec 16; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ, Gordon JL.
    Br J Pharmacol; 1974 May 16; 51(1):123P. PubMed ID: 4441772
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
    Petrov MN, Vashkinel' VK.
    Probl Gematol Pereliv Krovi; 1977 May 16; 22(5):18-23. PubMed ID: 267283
    [No Abstract] [Full Text] [Related]

  • 15. Aggregation and release reaction in normal and abnormal platelets.
    Cronberg S.
    Acta Univ Carol Med Monogr; 1972 May 16; 53():75-7. PubMed ID: 4670757
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(2):241-51. PubMed ID: 5284903
    [No Abstract] [Full Text] [Related]

  • 20. Platelet clumping without pseudothrombocytopenia: a laboratory artifact in myeloproliferative disorders.
    d'Onofrio G, Mancini S, Starti S, Landolfi R, Mango G.
    Haematologica; 1985 Jun 30; 70(5):461-2. PubMed ID: 3937788
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.